Clinical and echocardiographic disease in patients starting end-stage renal disease therapy

Kidney International

Volumn 47, Issue 1, 1995, Pages 186-192

  Foley, Robert N ^b   Parfrey, Patrick S ^a   Harnett, John D ^b   Kent, Gloria M ^b   Martin, Christopher J ^b   Murray, David C ^b   Barre, Paul E ^b  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL;

EID: 0028939185     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1995.22     Document Type: Article

References (40)

1. U.S. Renal Data System, USRDA 1991 Annual Report. Bethesda. The National Institute of Diabetes and Digestive and Kidney Diseases, 1991
2. FASSBINDER W, BRUNNER FP, BRYNGER H, EHRICH JHH, GEERLINGS W, RAINE AEG, RIZZONE G, SELWOOD NH, TUVESON G, WINg AJ: Combined report on regular dialysis and transplantation in Europe XX, 1989. Nephrol Dial Transplant 6(Suppl 1):5-35, 1991
3. GREAVES SC, SHARPE DN: Cardiovascular disease in patients with end-stage renal failure. Aust NZ J Med 22:153-158, 1992
4. HUTCHINSON TA, THOMAS CD, MAC GIBBON B: Predicting survival in adults with end-stage renal failure: An age-equivalence index. Ann Intern Med 96:417-423, 1982
5. CHURCHILL DN, TAYLOR DW, COOK RJ, LE PLANTE P, BARRE P, CARTIER P, FAY W, GOLDSTEIN M, JINDAL K, MANDIN H, MCKENZIE J, MUIRHEAD N, PARFREY P, POSEN G, SLAUGHTER D, ULAN R, WERB R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234, 1992
6. COLLINS AJ, MA JZ, UMEN A, KESHAVIAH P: Urea index and other predictors of hemodialysis patient survival. Am J Kid Dis 23:272-282, 1994
7. LEVY D, GARRISON RJ, SAVAGE DD, KANNEL WR, CASTELLI WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566, 1990
8. GHALI JK, LIAO Y, SIMMONS B, CASTANER A, CAO G, COOPER RS: The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 117:831-836, 1992
9. KOREN MJ, DEVEREUX RB, CASALE PN, SAVAGE DD, LARAGH JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345-352, 1991
10. SILBERBERG JS, BARRE P, PRICHARD S, SNIDERMAN AD: Left ventricular hypertrophy: An independent determinant of survival in end stage renal failure. Kidney Int 36:286-290, 1989
11. LAUER MJ, EVANS JC, LEVY D: Prognostic implications of subclinical left ventricular dilatation in men free of overt cardiovascular disease (The Framingham Heart Study). Am J Cardiol 70:1180-1184, 1992
12. PARFREY PS, HARNETT JD, GRIFFITHS SM, TAYLOR R, HAND J, KING A, BARRE P: The clinical course of left ventricular hypertrophy in dialysis patients. Nephron 55:114-120, 1990
13. PARFREY PS, GRIFFITHS SM, HARNETT DJ, ET AL: Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease and ischemic heart disease in dialysis patients. Am J Nephrol 10:213-221, 1990
14. DEVEREUX RB, ALONSO DR, LUTAS EM, GOTTLIEB GJ, CAMPO E, SACHS I, REICHEK N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
15. POMBO JF, TROY BL, RUSSELL RO JR: Left ventricular volumes and ejection fractions by echocardiography. Circulation 43:480-490, 1971
16. PARFREY PS, HARNETT JD, GRIFFITHS SM, GAULT MH, BARRE P: Congestive heart failure in dialysis patients. Arch Int Med 148:1519-1525, 1988
17. LEVY D, SAVAGE DD, GARRISON RJ, ANDERSON KM, KANNEL WB, CASTELLI WP: Echocardiographic criteria for left ventricular hypertrophy: The Framingham Study. Am J Cardiol 59:956-960, 1987
18. HUWEZ FU, PRINGLE SD, MACFARLANE PW: A new classiification of left ventricular geometry based on M-mode echocardiography. Am J Cardiol 70:681-688, 1992
19. DIXON WJ, BROWN MB, ENGELMAN L, HILL MA, HENRICH RI (editors):- Statistical Software Manual, Berkeley, University of California Press, 1985
20. FOLEY RN, PARFREY PS, HEFFERTON D, SINGH I, SIMMS A, BARRETT BJ: Advance prediction of early death in patients starting maintenance dialysis. Am J Kid Dis 23:836-845, 1994
21. LONDON GM, FABIANI F, MARCHAIS SJ, DE VERNEJOUL MC, GUERIN AP, SAFAR ME, METIVIER F, LLACH F: Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 31:973-980, 1987
22. HUTTING J, KRAMER W, SCHUTTERLE G, WIZEMANN V: Analysis of left ventricular changes associated with chronic hemodialysis: A non-invasive follow-up study. Nephron 49:284-290, 1988
23. GREAVES SC, SANDERS GA, GAMBLE G, SHARPE DN, COLLINS JF: Cardiac function in chronic renal failure. (abstract) J Am Soc Nephrol 3:283, 1992
24. PARFREY PS, HARNETT JD, GRIFFITHS SM, GAULT MH, BARRE PE, GUTTMANN RD: Low-output left ventricular failure in end-stage renal disease. Am J Nephrol 7:184-191, 1987
25. HARNETT JD, PARFREY PS, GRIFFITHS SM, GAULT MH, BARRE PE, GUTTMANN RD: Left ventricular hypertrophy in end-stage renal disease. Nephron 49:284-290, 1988
26. HARNETT JD, KENT GM, BARRE PE, TAYLOR R, PARFREY PS: Risk factors for the devlopment of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. J Am Soc Nephrol 4:1486-1490, 1994
27. THEUSEN L, CHRISTIANSEN SS, MOGENSEN CE, HENNINGSEN P: Cardiac hyperfunction in insulin-dependent diabetics developing microvascular complications. Diabetes 37:851-856, 1988
28. GROSSMANN E, SHEMESH J, SHAMISS A, THALER M, CARROLL J, ROSENTHAL T: Left ventricular mass in diabetes-hypertension. Arch Intern Med 151:1001-1004, 1992
29. ROIG E, BETRIU A, CASTANER A, MAGRINA J, SANZ G, NAVARRO-LOPEZ F: Disabling angina pectoris with normal coronary arteries in patients undergoing long-term hemodialysis. Am J Med 71:431-434, 1981
30. ROSTAND SG, KIRK KA, RUTSKY EA: Dialysis-associated ischemic heart disease: Insights from coronary angiography. Kidney Int 25:653-659, 1984
31. LONDON GM, ZINS B, PANNIER B, NARET C, BERTHELOT JM, JACQUOR C, SAFAR M, DRUCHE TB: Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. Kidney Int 36:878-882, 1989
32. MAC DOUGALL IC, LEWIS NP, SAUNDERS MJ, COCHLIN DL, DAVIES ME, HUTTON RD, FEN KAH, COLES GA, WILLIAMS JD: Long-term cardiorespiratory effects of amelioration of renal anemia by erythropoietin. Lancet 335:489-493, 1990
33. SILBERBERG J, RACINE N, BARRE P, SNIDERMAN AD: Regression of left ventricular hypertrophy in dialysis following correction of anemia with recombinant human erythropoietin. Can J Cordial 6:1-4, 1990
34. ZEHNDER C, ZUBER M, SULZER M, MEYER B, STRAUMANN F, JENZER HR, BLUMBERG A: Influence of long-term ameloration of anemia and blood pressure on left ventricular hypertrophy in hemodialyzed patients. Nephron 64:202-206, 1992
35. WIZEMANN V, SCHAFER R, KRAMER W: Follow-up of changes induced by anemia compensation in normotensive hemodialysis patients with left ventricular hypertrophy. Nephron 64:202-206, 1993
36. ACCHIARDO SR, MOORE LW, LA TOUR PA: Malnutrition as the main factor in the morbidity and mortality of hemodialysis patients. Kidney Int 24(Suppl 16): 199-203, 1983
37. OWEN SR, LEW NL, YAN LIU SM, LOWRIE EG, LAZARUS JM: The urea reduction ratio and serum albumin concentrations as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329:1001-1006, 1993
38. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
39. SPIEGEL DM, BREYER JA: Serum albumin: A predictor of long-term outcome in peritoneal dialysis patients. Am J Kid Dis 23:283-285, 1994
40. CANELLA G, PAOLETTI E, DELFINEO R, PELOSO G, MOLINARI S, BATTISTA TRAVERSON G: Regression of left ventricular hypertrophy in hypertensive dialyzed patients on long-term antihypertensive therapy. Kidney Int 44:881-886, 1993